Adrenocorticosteroids Chapter 19
Adrenocorticosteroids = group of agents secreted by the adrenal cortex
Dental uses
Medical Uses
Mechanism of release
stress → hypothalamus releases CRF → pituitary releases ACTH → adrenal cortex releases hydrocortisone
. Classification of Steroids
glucocorticoids
mineralcorticoids
Disease States
Addison’s disease
Cushing’s syndrome
Mechanism of Action
steroid binds to receptor → forms steroid-receptor complex → complex enters nucleus, turns genes on/off
anti-inflammatory
Pharmacologic effects - palliative (not curative)
glucocorticoids prednisone, methylprednisolone, triamcinolone
1. anti-inflammatory
2. suppress allergic reactions
3. suppress immune response
mineralcorticoids
1. ↑ Na+ retention
2. ↑ K+ loss
3. ↑ edema, hypertension
ADR’s
Glucocorticooids (see fig 19-2, pg 243)
1. metabolic changes - look like Cushing’s syndrome (see fig. 19-3, pg 244)
2. infections - because of anti-inflammatory action
3. CNS - changes in personality and behavior
(euphoria with high dose, depression with lower dose)
4. peptic ulcer - corticosteroids stimulate stomach acid
5. impaired wound healing / osteoporosis - impaired synthesis of collagen
6. ophthalmic effects - increased intraoccular pressure
7. electrolyte / fluid balance - can have some mineralcorticoid action
8. adrenal crisis - adrenal gland atrophies with prolonged use; can be lethal
9. dental effects
a. slow healing of mucosal surfaces
b. oral candidiasis with steroid inhalers (asthma)
Medical Uses
1. Addison’s disease
2. Cushing’s syndrome (Rx, adrenal tumor, pituitary tumor)
3. autoimmune diseases
a. rheumatoid arthritis
b. collagen diseases
4. with chemotherapy in CA tx (anti-emetic/anti-nausea, and to reduce swelling which decreases pain)
5. asthma
6. emergencies - tx shock, tx adrenal crisis
7. tx inflammatory and allergic reactions (palliative only, not curative) (most common)
Dental Uses
1. oral lesions - tx of noninfectious inflammatory diseases (most common) RAS
2. oral surgery - ↓ post-op edema, trismus, and pain (?)
3. pulp procedures (?)
Dental Implications
1. GI - stimulate stomach acid, avoid Rx Salicylates(ASA) and NSAID’s
2. check BP - can exacerbate hypertension
3. glaucoma - avoid Rx anticholinergics
4. be aware of possible behavior changes
5. osteoporosis
6. infection - infection symptoms may be masked, pt. has decreased ability to fight infection
7. delayed wound healing - special care in suturing
8. adrenal crisis - only with severe stress
9. periodontal disease - interfere with body’s response to infection, osteoporosis
Steroid supplementation
most dental patients taking steroids having normal dental tx rendered DO NOT need additional steroids (see fig 19-4, pg 247)
OTHER HORMONES Chapter 20
Hormones
Pituitary Hormones (pituitary = “master gland”, hypophysis)
Anterior (adenohypophysis)
1. GH growth hormone (somatotropin)
gigantism
acromegaly
dwarfism
2. LH leutinizing hormone
3. FSH follicle stimulating hormone
4. TSH thyroid stimulating hormone (thyrotropin)
5. ACTH adrenocorticotropic hormone
6. PRL prolactin (leuteotropic hormone LTH)
7. β - lipotropin
Posterior (neurohypophysis)
1. Vasopressin (antidiuretic hormone - ADH)
2. Oxytocin
Thyroid Hormones
Iodine-containing
1. T3 (tri-iodo-thyronine)
2. T4 (thyroxine)
Hypothyroid
child: cretinism
adult: myxedema
Hyperthyroid
thyrotoxicosis
Grave’s disease
Plummer’s disease
Hashimoto’s disease
Calcitonin
Pancreatic Hormones
Insulin
Glucagon
Diabetes mellitus: def. abnormal carbohydrate metabolism with inappropriate hyperglycemia
Type I (IDDM, juvenile onset)
Type II (NIDDM, adult onset)
Systemic complications
Oral complications
Management of DM patient
Evaluation
Medical emergencies
Hypoglycemia
Hyperglycemia
Drugs used to manage diabetes (add’l resource:
Type I
Insulin: Lantus, Humalog, Humulin N, Humulin 70/30, Novolog Mix 70/30, Novolin 70/30
Type II
Sulfonylureas: glimepiride, glyburide, glipizide (secretagogues)
MA: ↑ release of insulin from beta cells, ↓ serum glucagon, ↑ insulin sensitivity in target
tissues
ADR’s: blood dyscrasias, GI, cutaneous, liver damage
meglitinide derivatives (non-sulfonylurea secretagogues):
repaglinide (Prandin) nateglinide (Starlix)
MA: ↑ release of insulin from beta cells,
ADR’s: must be taken with meals
Biguanides: metformin
MA: ↓ hepatic production of glucose, ↑ insulin sensitivity in target tissues
ADR’s: GI, lactic acidosis
thiazolidinediones (glitazones): Actos, Avandia
MA: ↑ insulin sensitivity in target tissues
ADR’s: weight gain, hepatotoxicity
new drugs
exenatide (Byetta) (secretagogue, incretin mimetic, glucagon-like peptide / GLP-1)
MA: ↑ release of insulin from beta cells, ↓ serum glucagon, ↑ satiety
ADR’s: GI, risk of hypoglycemia when used with other oral diabetic agents
pramlintide (Symlin) (amylin analog)
MA: modulation gastric emptying, prevent postprandial rise in plasma glucagon,
↑ satiety Amylin secreted along with insulin by pancreatic β- cells
ADR’s: GI,risk of hypoglycemia when used with other oral diabetic agents
DPP-4 inhibitors (Januvia / sitaglipton)
MA: ↑insulin synthesis, oppose glucagon
ADR’s: weight gain whenused with sulfonylurea
α-glucosidase inhibitors ( acarbose)
MA: delay/prevent digestion of ingested carbohydrate (small intestine), delays glucose adsorption
ADR’s: flatulence, GI
Female Sex Hormones
Estrogens: Premirin, Evista, Estradiol
Progestins
Oral contraceptives: NuvaRing, Loestrin 24 Fe
Management of patient taking oral contraceptives:
Drug interactions:
Male Sex Hormones (testosterone)
Other Agents
clomiphene
leuprolide
tamoxifen
danazol
aromatase inhibitors